We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.53B
AUM Growth
+$93.1M
Cap. Flow
+$472M
Cap. Flow %
5.53%
Top 10 Hldgs %
16.89%
Holding
812
New
193
Increased
197
Reduced
149
Closed
231

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$188M
2
ABBV icon
AbbVie
ABBV
+$121M
3
EA icon
Electronic Arts
EA
+$112M
4
ADSK icon
Autodesk
ADSK
+$97.3M
5
KEYS icon
Keysight
KEYS
+$92.2M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$123M
2
APH icon
Amphenol
APH
+$113M
3
COR icon
Cencora
COR
+$108M
4
MSFT icon
Microsoft
MSFT
+$104M
5
HPQ icon
HP
HPQ
+$91.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.52%
2 Technology 26.19%
3 Industrials 9.44%
4 Energy 7.95%
5 Consumer Discretionary 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
351
Pacira BioSciences
PCRX
$1.02B
$3.33M 0.04%
108,407
+31
+0% +$1.12K
RENE
352
DELISTED
Cartesian Growth Corp II
RENE
$3.24M 0.04%
300,000
– –
SVII
353
DELISTED
Spring Valley Acquisition Corp II
SVII
$3.23M 0.04%
300,000
– –
ZBRA icon
354
Zebra Technologies
ZBRA
$17.2B
$3.21M 0.04%
+13,574
New +$3.69M
SPRY icon
355
ARS Pharmaceuticals
SPRY
$551M
$3.2M 0.04%
847,054
+176,967
+26% +$1.16M
EVCM icon
356
EverCommerce
EVCM
$1.88B
$3.17M 0.04%
315,607
-40,808
-11% -$438K
SGEN
357
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$3.1M 0.04%
14,600
+100
+0.7% +$20K
DYN icon
358
Dyne Therapeutics
DYN
$4.83B
$3.01M 0.04%
335,884
-46,692
-12% -$503K
TDC icon
359
Teradata
TDC
$2.54B
$3.01M 0.04%
+66,826
New +$3.27M
SITE icon
360
SiteOne Landscape Supply
SITE
$4.3B
$2.99M 0.04%
18,298
+9,760
+114% +$1.59M
CRI icon
361
Carter's
CRI
$1.48B
$2.98M 0.03%
+43,108
New +$3.08M
FRPT icon
362
Freshpet
FRPT
$3.28B
$2.96M 0.03%
+44,926
New +$3.22M
CLDX icon
363
Celldex Therapeutics
CLDX
$3.26B
$2.96M 0.03%
107,496
+52,997
+97% +$1.66M
IOVA icon
364
Iovance Biotherapeutics
IOVA
$2.77B
$2.94M 0.03%
+646,295
New +$4.22M
CRM icon
365
Salesforce
CRM
$153B
$2.92M 0.03%
+14,405
New +$3.11M
ENX
366
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$2.89M 0.03%
348,976
– –
TNGX icon
367
Tango Therapeutics
TNGX
$4.72B
$2.81M 0.03%
250,000
-13,645
-5% -$83.2K
LRMR icon
368
Larimar Therapeutics
LRMR
$436M
$2.8M 0.03%
709,681
-972,232
-58% -$3.68M
FWRG icon
369
First Watch Restaurant Group
FWRG
$768M
$2.75M 0.03%
159,305
+30,206
+23% +$557K
PGNY icon
370
Progyny
PGNY
$2.37B
$2.75M 0.03%
+80,818
New +$3.05M
CHS
371
DELISTED
Chicos FAS, Inc.
CHS
$2.7M 0.03%
+361,484
New +$1.94M
SGMT icon
372
Sagimet Biosciences
SGMT
$540M
$2.64M 0.03%
+300,171
New +$4M
LZB icon
373
La-Z-Boy
LZB
$1.63B
$2.64M 0.03%
+85,488
New +$2.63M
ARW icon
374
Arrow Electronics
ARW
$11.4B
$2.63M 0.03%
+20,970
New +$2.8M
KMB icon
375
Kimberly-Clark
KMB
$36.1B
$2.58M 0.03%
+21,313
New +$2.75M
13 14
15
16 17

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Woodline Partners held 812 positions worth $8.53B, up 1.1% from $8.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $472M of net new capital in Q3 2023, opening 193 new positions and adding to 197 existing holdings. Its largest new stake was Analog Devices: 1,016,972 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hess, an estimated $123M trimmed.

  • Woodline Partners's largest Q3 2023 buy was Analog Devices: 1,016,972 shares worth $178M.
  • Woodline Partners added most to AbbVie in Q3 2023, an estimated $121M increase.
  • Woodline Partners's biggest Q3 2023 reduction was Hess, cutting an estimated $123M.
  • Woodline Partners fully exited HP in Q3 2023, selling an estimated $91.2M.
  • Woodline Partners's ten largest holdings make up 17% of its $8.53B portfolio in Q3 2023.
  • Woodline Partners opened 193 new positions and closed 231 in Q3 2023.
  • Woodline Partners's portfolio value rose 1.1% quarter-over-quarter to $8.53B.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.